Giuseppe Curigliano, President Elect of ESMO and Member of the Editorial Board at OncoDaily, shared a post on LinkedIn:
“An exciting and transformative day at ESMO25!
The Presidential Session showcased groundbreaking clinical trial data with the potential to reshape standards of care across multiple cancer types. These are the moments when science directly translates into better patient outcomes—and it’s a privilege to witness it firsthand. Gratitude to all the investigators, patients, and collaborators driving oncology forward. The future of cancer care is being written right here.”
You Can Also Read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
